RESEARCH PROGRESS OF DUB ENZYME IN HEPATOCELLULAR CARCINOMA

Research Progress of DUB Enzyme in Hepatocellular Carcinoma

According to GLOBOCAN 2021 cancer incidence and mortality statistics compiled by the International Agency for Research on Cancer, hepatocellular carcinoma (HCC) is the most common malignancy in the human liver and one of the leading causes of cancer death worldwide.Although there have been great advances in the treatment of HCC, such as regofenib,

read more



Computational Drug Repositioning for Peripheral Arterial Disease: Prediction of anti-inflammatory and pro-angiogenic therapeutics

Peripheral arterial disease copyright Oil (PAD) results from atherosclerosis that leads to blocked arteries and reduced blood flow, most commonly in the arteries of the legs.PAD clinical trials to induce angiogenesis to improve blood flow conducted in the last decade have not succeeded.We have recently constructed PADPIN, protein-protein interactio

read more

Could real-time ultrasonography guidance be useful for the effective deployment of FemoSeal in common femoral arteriotomy?

A vascular closure device is used for hemostasis Floor Care Concrete after a procedure involving an arterial puncture.The increasing frequency of endovascular arterial interventions has caused these devices to play a more important role in clinical practice.FemoSeal is a popular vascular closure device, and its safety and effectiveness have been ve

read more